NCT06387667View on ClinicalTrials.gov

Characterizing Diversity and Antifungal Resistance in Immunocompromised ICU Patients With Respiratory Tract Infections

NANot yet recruitingINTERVENTIONAL
Enrollment

250

Participants

Timeline

Start Date

December 1, 2025

Primary Completion Date

December 1, 2026

Study Completion Date

June 1, 2027

Conditions
Immunocompromised ICU Patients With Respiratory Tract Infections
Interventions
DIAGNOSTIC_TEST

Complete blood count

blood sample

DIAGNOSTIC_TEST

C-reactive protein, urea, creatinine, Random blood glucose (RBG), aspartate aminotransferase (AST), alanine aminotransferase (ALT)

serum sample

RADIATION

CT chest

Computed tomography of the chest

DIAGNOSTIC_TEST

Microscopic examination

sputum and bronchoalveolar lavage (BAL)

DIAGNOSTIC_TEST

culture and sensitivity

for bacterial and fungal

All Listed Sponsors
lead

New Valley University

OTHER

NCT06387667 - Characterizing Diversity and Antifungal Resistance in Immunocompromised ICU Patients With Respiratory Tract Infections | Biotech Hunter | Biotech Hunter